Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × carotuximab × Clear all

NCT01806064 2020-10-19

Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma

Phase 1/2 Terminated

173 enrolled 17 charts

Carcinoma, Renal Cell